Immunosuppression in human tumor-host interaction: Role of cytokines and alterations in signal-transducing molecules

Springer Seminars in Immunopathology

Volumn 18, Issue 2, 1996, Pages 227-242

  Kiessling, Rolf ^a,b   Kono, Koji ^a,c   Petersson, Max ^a   Wasserman, Ken ^a  

^a KAROLINSKA INSTITUTE   (Sweden)

^b KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^c UNIVERSITY OF YAMANASHI   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CD3 ANTIGEN; CYTOKINE; HYDROGEN PEROXIDE; T LYMPHOCYTE RECEPTOR;

HELPER CELL; HUMAN; HUMAN CELL; IMMUNE DEFICIENCY; IMMUNOSURVEILLANCE; NATURAL KILLER CELL; PERIPHERAL LYMPHOCYTE; PRIORITY JOURNAL; REVIEW; SIGNAL TRANSDUCTION; T LYMPHOCYTE SUBPOPULATION; TUMOR ASSOCIATED LEUKOCYTE; TUMOR IMMUNOLOGY;

ANIMALS; CYTOKINES; HUMANS; IMMUNOSUPPRESSION; NEOPLASMS; SIGNAL TRANSDUCTION;

EID: 0029811971     PISSN: 03444325     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF00820668     Document Type: Review

References (100)

1. Alexander JP, Kudoh S, Melsop KA, Hamilton TA, Edinger MG, Tubbs RR, Sica D, Tuason L, Klein E, Bukowski RM, Finke JH (1993) T-cells infiltrating renal cell carcinoma display a poor proliferative response even though they can produce interleukin 2 and express interleukin 2 receptors. Cancer Res 53:1380
2. 2, Ia and tumor necrosis factor-α. Immunopharmacology 25:215
3. Alleva, DG, Walker TM, Elgen KD (1995) Induction of macrophage suppressor activity by fibrosarcoma-derived transforming growth factor-β1 : contrasting effects on resting and activated macrophages. J Leukoc Biol 57:919
4. Andersson P, Caligiuri M, O'Brien C, Manley T, Ritz J, Schlossman SF (1990) Fc γ receptor type III (CD16) is included in the NK receptor complex expressed by human natural killer cells. Proc Natl Acad Sci USA 87:2274
5. Aoe T, Okamoto Y, Saito T (1995) Activated macrophages induce structural abnormalities of the T cell receptor-CD3 complex. J Exp Med 181:1881
6. Assenmacker M, Schmitz J, Radbruch A (1994) Flow cytometric determination of cytokines in activated murine T helper lymphocytes: expression of interleukin-10 in interferon-γ and in interleukin-4-expressing cells. Eur J Immunol 24:1097
7. Baeuerle PA (1991) The inducible transcription activator NFκB: regulation by distinct protein subunits. Biochim Biophys Acta 1072:63
8. Baniyashi M, Garcia-Morales P, Bounifacino TS, Samelson LE, Klausner RD (1988) Disulfide linkage of the ς and the η chains of T-cell receptor. J Biol Chem 263:9874
9. Baxevanis CN, Papamichail M (1994) Characterisation of the anti-tumor immune response in human cancers and strategies for immunotherapy. Crit Rev Oncol Hematol 16:157
10. Cenciarelli C, Hou D, Hsu K-C, Rellahan BL, Wiest DL, Smith HT, Fried VA, Weissman AM (1992) Activation-induced ubiquitination of the T-cell antigen receptor. Science 257:795
11. Chao T-Y, Ting C-S, Yeh M-Y, Chang J-Y, Wang C-C, Ming Chu T (1995) Effects of indomethacin on lymphokine-activated killer cell activities in cancer patients. Tumour Biol 16:230
12. Chen Q, Daniel V, Maher DW, Hersey P (1994) Production of IL-10 by melanoma cells: examination of its role in immunosuppression mediated by melanoma. Int J Cancer 56:755
13. Chen W-F, Zlotnik A (1991) IL-10: a novel cytotoxic T cell differentiation factor. J Immunol 147:528
14. + cell numbers and clinical staging. J Clin Invest 84:1892
15. Correa M, Sica A, Ghosh P, Longo DL, Ochoa AC (1995) TCR chronic stimulation as an in vitro model to study anergy in human cells (abstract). Abstracts of the 9th International Congress of Immunology, July 23-29, 1995. www.sciencexchange.com/immunologist/congress.html, 3622
16. Ebert EC, Roberts AI, O'Connell SM, Robertson FM, Nagase H (1987) Characterisation of an immunosuppressive factor derived from colon cancer cells. J Immunol 138:2161
17. Enk A, Katz SI (1992) Identification and induction of keratinocyte-derived IL-10. J Immunol 149:92
18. lck in T-cells infiltrating human renal cell carcinoma. Cancer Res 53:5613
19. Elsasser-Beile U, Kleist S von, Fischer R, Martin M, Wetterauer U, Gallati H, Monting JS (1993) Impaired cytokine production in whole blood cell cultures from patients with urological carcinomas. J Cancer Res Clin Oncol 119:430
20. Elsasser-Beile U, Kleist S von, Fischer R, Monting JS (1992) Impaired cytokine production in whole blood cell cultures from patients with colorectal carcinomas as compared to benign colorectal tumors and controls. J Clin Lab Anal 6:311
21. Franco JL, Ghosh P, Wiltrout RH, Carter CRD, Zea AH, Momozaki N, Ochoa AC, Longo DL, Sayers TJ, Komschlies KL (1995) Partial degradation of T-cell signal transduction molecules by contaminating granulocytes during protein extraction of splenic T cells from tumor-bearing mice. Cancer Res 55:3840
22. Fuji T, Igarashi T, Kishimoto S (1987) Significance of suppressor macrophages for immune surveillance of tumor-bearing mice. J Natl Cancer Inst 78:509
23. Fujimoto S, Greene MI, Sehon AH (1976) Regulation of the immune response to tumor anti-gens. II. The nature of immunosuppressor cells in tumor-bearing hosts. J Immunol 116:791
24. Gastl GA, Abrams JS, Nanus DM, Oosterkamp R, Silver J, Liu F, Chen M, Albino AP, Albino AP, Bander NH (1993) Interleukin-10 production by human carcinoma cell lines and its relationship to interleukin-6 expression. Int J Cancer 55:69
25. Ghalib H, Piuvezam R, Skeiky Y, Siddig M, Hashim F, El-Hassan A, Russo D, Reed S (1993) Interleukin 10 production correlates with pathology in human Leishmania donovani infections. J Clin Invest 92:324
26. Ghosh P, Komschlies KL, Cippitelli M, Longo DL, Subleski J, Ye J, Sica A, Young HA, Wiltrout RH, Ochoa AC (1995) Gradual loss of T-helper 1 populations in spleens of mice during progressive tumor growth. J Natl Cancer Inst 87:1478
27. Ghosh P, Sica A, Young HA, Ye J, Franco JL, Wiltrout RH, Longo DL, Rice NR, Komschlies KL (1994) Alterations in NFκB/Rel family proteins in splenic T-cells from tumor-bearing mice and reversal following therapy. Cancer Res 54:2969
28. Ghosh P, Zea AH, Longo DL, Strobl SL, Ochoa A C (1995) Loss of Th1 DNA-binding pattern and alterations in signal transduction molecules in T cells of renal cell carcinoma patients (abstract). Abstracts of the 9th International Congress of Immunology, July 23-29, 1995. www.sciencexchange.com/immunologist/congress.html, 3936
29. Giovarelli M, Musiani P, Modesti A, Dellabona P, Casorati G, Allione A, Consalvo M, Cavallo F, Pierro F di, Giovanni C de, Musso T, Forni G (1995) Local release of IL-10 by transfected mouse mammary adenocarcinoma cells does not suppress but enhances antitumor reaction and elicits a strong cytotoxic T lymphocyte and antibody-dependent immune memory. J Immunol 155:3112
30. Golumbek PT, Lazenby AJ, Levitsky HI, Jaffee LM, Karasuyama H, Baker M, Pardoll DM (1991) Treatment of established renal cancer by tumor cells engineered to secrete interleukin-4. Science 254:713
31. Gotlieb WH, Abrams JS, Watson JM, Velu TJ, Berek JS, Martinez-Maza O (1992) Presence of interleukin 10 (IL-10) in the ascites of patients with ovarian and other intra-abdominal cancers. Cytokine 4:385
32. Grever MR, Thompson VN, Balcerzak SP, Sagone LA Jr (1980) The effect of oxidant stress on human lymphocyte cytotoxicity. Blood 56:284
33. Gunji Y, Hori S, Aoe T, Asano T, Ochiai T, Isono K, Saito T (1994) High frequency of cancer patients with abnormal assembly of the T cell receptor-CD3 complex in peripheral blood T lymphocytes. Jpn J Cancer Res 85: 1189
34. Hellstrand K, Asea A, Dahlgren C, Hermodsson S (1994) Histaminergic regulation of NK cells. J Immunol 153:4940
35. Hellström I, Warner GA, Hellström KE, Sjögren HO (1973) Sequential studies on cell mediated tumor immunity and blocking serum activity in ten patients with malignant melanoma. Int J Cancer 11:280
36. Huang M, Wang J, Lee P, Sharma S, Mao JT, Meissner H, Uyemura K, Modlin R, Wollman J, Dubinett SM (1995) Human non-small cell lung cancer cells express a type 2 cytokine pattern. Cancer Res 55:3847
37. Irving BA, Weiss A (1991) The cytoplasmic domain of the T-cell receptor ς chain is sufficient to couple to receptor-associated signal transduction pathways. Cell 64:891
38. Kadish AS, Dovle AT, Steinhauer EH, Ghossein NA (1981) Natural cytotoxicity and interferon production in human cancer: deficient natural killer activity and normal interferon production in patients with advanced disease. J Immunol 127:1817
39. + T lymphocytes. Science 256:1452
40. 2 subsets: paradigms lost? Immunol Today 16:374
41. Kim J, Modlin RL, Moy RL, Dubinett SM, McHugh T, Nickoloff BJ, Uyemura K (1995) II-10 production in cutaneous basal and squamous cell carcinomas. A mechanism for evading the local T cell immune response. J Immunol 155:2240
42. Kirchner H (1978) Suppressor cells of immune reactivity in malignancy. Eur J Cancer 14:453
43. Klausner RD, Lippincott-Schwarts J, Bonifacing J (1990) The T cell antigen receptor: insights into organelle biology. Annu Rev Cell Biol 6:403
44. Kong FM, Anscher MS, Murase T, Abbott BD, Iglehart JD, Jirtle RL (1995) Elevated plasma transforming growth factor-β1 levels in breast cancer patients decrease after surgical removal of the tumor. Ann Surg 222:155
45. Kono K, Salazar-Onfray F, Petersson M, Hansson J, Masucci G, Wasserman K, Nakazawa T, Anderson P, Kiessling R (1996) Hydrogen peroxide secreted by tumor-derived macrophages down-modulates signal-transducing ς molecules and inhibits tumor specific T-cell and NK-mediated cytotoxicity. Eur J Immunol (in press)
46. Lai P, Rabinowich H, Crowley-Nowik PA, Bell MC, Mantovani G, Whiteside TL (1996) Alterations in expression and function of signal transducing proteins in tumor-associated T and NK cells in patients with ovarian carcinoma. Clin Cancer Res (in press)
47. Lattime EC, Mastrangelo MJ, Bagasra O, Li W, Berd D (1995) Expression of cytokine mRNA in human melanoma tissues. Cancer Immunol Immunother 41:151
48. Lattime EC, Mastrangelo MJ, Berd D (1994) Human metastatic melanoma lesions and cell lines express mRNA for IL-10. Proc Am Assoc Cancer Res 35:489
49. fyn, ZAP-70, and CD3 ς despite suppressed cytolytic activity. J Exp Med 182:1029
50. Levey DL, Srivastava PK (1996) Alterations in T lymphocytes of cancer-bearers: whence specificity? Immunol Today (in press)
51. Li X, Liu J, Park J-K, Hamilton TA, Rayman P, Klein E, Edinger M, Tubbs M, Bukowski R, Finke J (1994) T cells from renal cell carcinoma patients exhibit an abnormal pattern of kappaB-specific DNA-binding activity: a preliminary report. Cancer Res 54:5424
52. Liou HC, Baltimore D (1993) Regulation of the NF-kappa B/rel transcription factor and I kappa B inhibitor system. Curr Opin Cell Biol 5:477
53. Lu C-P, Ueda R, She J, Sancho J, Wang B, Weddell G, Loring J, Kurahara C, Dudley ED, Hayday A, Terhorst C, Huang M (1993) Abnormal T-cell development in CD3 ς mutant mice and identification of a novel T-cell population in the intestine. EMBO J 12:4863
54. Lüscher U, Filgueira L, Juretic A, Zuber M, Lüscher NJ, Heberer M, Spagnoli GC (1994) The pattern of cytokine gene expression in freshly excised human metastatic melanoma suggests a state of reversible anergy of tumor-infiltrating lymphocytes. Int J Cancer 57:612
55. MacNeil IA, Suda T, Moore KW, Mosmann TR, Zlotnik A (1990) IL-10: a novel cytokine growth factor for mature and immature T cells. J Immunol 145:4167
56. Madrenas J, Wange RL, Wang JL, Isakov N, Samelson LE, Germain RN (1995) Phosphorylation without ZAP-70 activation induced by TCR antagonists or partial agonists. Science 267:515
57. Maeurer MJ, Martin DM, Castelli C, Elder E, Leder G, Storkus WJ, Lotze MT (1995) Host immune response in renal cell cancer: interleukin-4 (IL-4) and IL-10 mRNA are frequently detected in freshly collected tumor-infiltrating lymphocytes. Cancer Immunol Immunother 41:111
58. Malissen M, Gillet A, Rocha B, Trucy J, Vivier E, Boyer C, Köntgen F, Brun N, Mazza G, Spanopoulou E, Guy-Grand D, Malissen B (1993) T-cell development in mice lacking the CD3-ς/η gene. EMBO J 12:4347
59. Mantovani A, Bottazzi B, Colotta F, Sozzani S, Ruco L (1992) The origin and function of tumor-associated macrophages. Immunol Today 13:265
60. Mantovani A, Bottazzi B, Sozzani S, Peri G, Allavena P, Dong QG, Vecchi A, Colotta F (1993) Cytokine regulation of tumor-associated macrophages. Res Immunol 144:280
61. Matsuda M, Petersson M, Lenkei R, Raupin J-L, Magnusson I, Mellstedt H, Anderson P, Kiessling R (1995) Alterations in the signal-transducing molecules of T-cells and NK-cells in colorectal tumor-infiltrating gut mucosal and peripheral lymphocytes: correlation with the stage of the disease. Int J Cancer 61:765
62. Matsuda M, Salazar F, Petersson M, Masucci G, Hansson J, Pisa P, Zhang QJ, Masucci MG, Kiessling R (1994) Interleukin 10 pre-treatment protects target cells from tumor- and allo-specific cytotoxic T cells and down regulates HLA class I expression. J Exp Med 180:2371
63. Michiel DF, Oppenheim JJ (1992) Cytokines as positive and negative regulators of tumor promotion and progression. Semin Cancer Biol 3:3
64. Miescher S, Stoeck M, Qiao L, Barras C, Barrelet L, Fliedner V von (1988) Proliferative and cytolytic potentials of purified human tumor infiltrating T lymphocytes. Impaired response to mitogen-driven stimulation despite T cell receptor expression. Int J Cancer 42:659
65. Mizoguchi H, O'Shea JJ, Longo DL, Loeffler CM, McVicar DW, Ochoa AC (1992) Alteration in signal transduction molecules in T lymphocytes from tumor-bearing mice. Science 258:1795
66. Nakagomi H, Petersson M, Magnusson I, Juhlin C, Matsuda M, Mellstedt H, Taupin I-L, Vivier E, Anderson P, Kiessling R (1993) Decreased expression of the signal transducing ς chains in tumor infiltrating T cells and NK cells of patients with colorectal carcinoma. Cancer Res 53:5610
67. Nakagomi H, Pisa P, Pisa EK, Yamamoto Y, Halapi E, Backlin K, Juhlin C, Kiessling R (1995) Lack of interleukin-2 (IL-2) expression and selective expression of IL-10 mRNA in human renal cell carcinoma, Int J Cancer 63:366
68. Oswald IP, Gazzinelli RT, Sher A, James SL (1992) IL-10 synergizes with IL-4 and transforming growth factor-β to inhibit macrophage cytotoxic activity. J Immunol 148:3578
69. Paolini R, Kinet J-P (1993) Cell surface control of the multiubiquitination and deubiquitination of high-affinity immunoglobulin E receptors. EMBO J 12:779
70. Pisa P, Halapi E, Pisa EK, Gerdin E, Hising C, Bucht A, Gerdin B, Kiessling R (1992) Selective expression of interleukin 10, interferon and granulocyte-macrophage colony-stimulating factor in ovarian cancer biopsies. Proc Natl Acad Sci USA 89:7708
71. Powrie F, Menon S, Coffman RL (1993) Interleukin-4 and interleukin-10 synergize to inhibit cell-mediated immunity in vivo. Eur J Immunol 23:3043
72. fyn. J Immunol 149:2887
73. Reinhold U, Abken H, Kukel S, Goeden B, Uerlich M, Neumann U, Kreysel HW (1991) Tumor-infiltrating lymphocytes isolated from a Ki-1-positive large cell lymphoma of the skin. Cancer 68:2155
74. Richter G, Kruger-Krasagakes S, Hein G, Huls C, Schmitt E, Diamantstein T, Blankenstein T (1993) Interleukin 10 transfected into Chinese hamster ovary cells prevents tumor growth and macrophage infiltration. Cancer Res 53:4134
75. Romeo C, Amiot M, Seed B (1992) Sequence requirements for induction of cytolysis by the T-cell antigen/Fc receptor chain. Cell 68:889
76. Roth C, Rochlitz C, Kourilsky P (1994) Immune response against tumors. Adv Immunol 57:281
77. Roth JA, Osborne BA, Ames RS (1983) Immunoregulatory factors derived from human tumors. II. Partial purification and further immunochemical characterisation of a human sarcoma-derived immunosuppressive factor expressing HLA-DR and immunoglobulin-related determinants. J Immunol 130:303
78. Sagone AL Jr, Husney R, Guter H, Clark L (1984) Effect of catalase on the proliferation of human lymphocytes to phorbol myristate acetate. J Immunol 133:1488
79. Salazar F, Petersson M, Franksson L, Matsuda M, Kärre K, Kiessling R (1995) Interleukin-10 converts mouse lymphoma cells to a CTL resistant, NK sensitive phenotype with low but peptide inducible MHC class I expression. J Immunol 154: 6291
80. Salgame P, Abrams JS, Clayberger C, Goldstein H, Convit J, Moldion RL, Bloom BR (1992) Differing lymphokine profiles of functional subsets of human CD4 and CD8 T cell clones. Science 254:279
81. Salvadori S, Gansbacher B, Pizzimenti AM, Zier KS (1994) Abnormal signal transduction by T cells of mice with parental tumors is not seen in mice bearing IL-2-secreting tumors. J Immunol 153:5176
82. + T cell clones isolated from human renal cell carcinoma possess the functional characteristics of TH2 helper cells. Cell Immunol 150:114
83. Sher A, Coffman RL (1992) Regulation of immunity to parasites by T cells and T cell-derived cytokines. Annu Rev Immunol 10:385
84. Sloan-Lancaster J, Shav AS, Rothbard JB, Allen PM (1994) Partial T-cell signalling: altered phospho-ς and lack of Zap 70 recruitment in APC-induced T-cell anergy. Cell 79:913
85. Stutman O (1975) Immunodepression and malignancy. Adv Cancer Res 22:261
86. Sulitzeanu D (1993) Immunosuppressive factors in human cancer. Adv Cancer Res 60:247
87. Tartour E, Latour S, Mathiot C, Thiounn N, Mosseri V, Joyeux I, Dubios D'Enghien C, Lee R, Debre B, Fridman WH (1995) Variable expression of CD3-ς chain in tumor-infiltrating lymphocytes (TIL) derived from renal-cell carcinoma: relationship with TIL phenotype and function. Int J Cancer 63:205
88. Taupin J-L, Anderson P (1994) Activation-induced proteolysis of the cytoplasmic domain of ς in T-cell receptors and Fc receptors. Eur J Immunol 24:3000
89. Vitolo D, Letessier EM, Johnson JT, Whiteside TL (1992) Immunologic effector cells in head and neck cancer. Monogr Natl Cancer Inst 13:203
90. Vitolo D, Zerbe T, Kanbour A, Dahl C, Herberman RB, Whiteside TL (1992) Expression of mRNA for cytokines in tumor infiltrating mononuclear cells in ovarian adenocarcinoma and invasive breast cancer. Int J Cancer 51:573
91. Vivier E, Rochet N, Kochan JP, Presky DH, Schlossman SF, Andersson P (1991) Structural similarity between Fc receptors and T-cell receptors. J Immunol 147:4263
92. Waal Maleefyt R de, Abrams J, Bennett B, Figdo CG, Vries JE de (1991) Interleukin 10 (IL-10) inhibits cytokine synthesis by human monocytes: an autoregulatory role of IL-10 produced by monocytes. J Exp Med 174:1209
93. Wang Q, Stanley J, Kudoh S, Myles J, Kolenko V, Yi T, Tubbs R, Bukowski R, Finke J (1995) T cells infiltrating non-Hodgkin's B cell lymphomas show altered tyrosine phosphorylation pattern even though T cell receptor/CD3-associated kinases are present. J Immunol 155:1382
94. Wahl SM, McCartney-Francis N, Mergenhagen SE (1989) Inflammatory and immunomodulatory roles of TGF-β. Immunol Today 10:258
95. Wegener AM, Letourneur F, Hoeveler A, Brocker T, Luton F, Malissen B (1992) The T-cell-receptor/CD3 complex is composed of at least two autonomous transduction modules. Cell 68:83
96. Weissman AM, Baniyash M, Hou D, Samuelson LE, Burgess WH, Klausner RD (1988) Molecular cloning of the ς chain of the T-cell antigen receptor. Science 239:1018
97. Yamamura M, Uyemura K, Deans RJ, Weinberg K, Rea TH, Bloom BR, Modlin RL (1991) Defining protective responses to pathogens: cytokine profiles in leprosy lesions (published erratum appears in Science 1992:255:12). Science 254:277
98. Yang C, Hellström KE, Mizuno MR, Chen L (1995) In vitro priming of tumor-reactive cytolytic T lymphocytes by combining IL-10 with B7-CD28 co-stimulation. J Immunol 155:3897
99. Zea AH, Curti BD, Longo DL, Alvord WG, Strobi SL, Mizoguchi H, Creekmore SP, O'Sea JJ, Powers GC, Urba WJ, Ochoa AC (1995) Alterations in T-cell receptor and signal transduction molecules in melanoma patients. Clin Cancer Res 1:1327
100. Zea AH, Ghosh P, Ochoa MT, Longo DL, Falabella R, Harvey L, Valderrama L, Saravia N, Moreno LH, Ochoa AC (1995) T lymphocytes from leprosy patients present alterations in nuclear transcription factors and in signal transduction (abstract). Abstracts of the 9th International Congress of Immunology, July 23-29, 1995. www.sciencexchange.com/immunologist/congress.html, 3314